Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Post-Approval (Research/Post Marketing/Phase IV)
Study Claims Celgene (CELG) Drug Can Drive HIV Out Of Hiding 7/24/2014 6:34:56 AM
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands 7/21/2014 10:47:02 AM
Shire Reports Results From Two Head-To-Head Studies Comparing Vyvanse® With Concerta® In ADHD Study 7/18/2014 6:56:54 AM
Bristol-Myers Squibb Company (BMY) And Pfizer Inc. (PFE) Announce Enrollment Of First Patient In Phase IV EMANATE Trial To Assess Effectiveness And Safety Of Eliquis® (Apixaban) In Patients With NVAF Undergoing Cardioversion 7/17/2014 9:42:56 AM
FDA Grants Astellas Qualified Infectious Disease Product Designation For Isavuconazole For The Treatment Of Invasive Candidiasis 7/16/2014 10:35:01 AM
ACell, Inc. Initiates Post-Market Study Of MatriStem® Pelvic Floor Matrix 7/15/2014 9:30:19 AM
Celgene (CELG)'s OTEZLA® Misses Mark In Phase 3 Spinal Arthritis Study 7/9/2014 7:18:47 AM
Controversial Trial Discovers No Benefit For Expensive The Medicines Company (MDCO) Drug 7/8/2014 6:30:00 AM
Merck & Co., Inc. (MRK)'s Gardasil HPV Vaccine Doesn't Increase Blood Clot Risk 7/9/2014 6:11:09 AM
Merck & Co., Inc. (MRK)'s Januvia Linked To Increase In Heart Failure Hospitalizations 7/7/2014 5:56:09 AM
Sunovion Pharmaceuticals Inc. Announces Data Published In The CHEST Journal From A One-Year, Large Simple Safety Study Evaluating BROVANA® (Arformoterol Tartrate) Inhalation Solution 7/8/2014 7:21:21 AM
Roche (RHHBY) Finds "Serious Flaws" In Recent Study Doubting Tamiflu's Effectiveness 7/1/2014 6:04:26 AM
FDA Grants Breakthrough Therapy Designation To Pradaxa® (Dabigatran Etexilate) Specific Investigational Antidote 6/30/2014 10:51:52 AM
Veloxis Pharmaceuticals A/S (VELO) Release: Envarsus® XR Demonstrates Lower Treatment Failure Rate In African-Americans Compared To Twice-Daily Tacrolimus (Prograf®) 6/30/2014 8:06:09 AM
InDex Pharmaceuticals AB Announces Results From COLLECT, A Clinical Trial Of Kappaproct® In The Treatment Of Moderate To Severe Ulcerative Colitis 6/27/2014 8:56:54 AM
1234567
//-->